218 related articles for article (PubMed ID: 16453287)
1. Hepatocyte growth factor and the Met system as a mediator of tumor-stromal interactions.
Matsumoto K; Nakamura T
Int J Cancer; 2006 Aug; 119(3):477-83. PubMed ID: 16453287
[TBL] [Abstract][Full Text] [Related]
2. Induction of hepatocyte growth factor in fibroblasts by tumor-derived factors affects invasive growth of tumor cells: in vitro analysis of tumor-stromal interactions.
Nakamura T; Matsumoto K; Kiritoshi A; Tano Y; Nakamura T
Cancer Res; 1997 Aug; 57(15):3305-13. PubMed ID: 9242465
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
Matsumoto K; Nakamura T; Sakai K; Nakamura T
Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
[TBL] [Abstract][Full Text] [Related]
4. Induction of hepatocyte growth factor in stromal cells by tumor-derived basic fibroblast growth factor enhances growth and invasion of endometrial cancer.
Yoshida S; Harada T; Iwabe T; Taniguchi F; Fujii A; Sakamoto Y; Yamauchi N; Shiota G; Terakawa N
J Clin Endocrinol Metab; 2002 May; 87(5):2376-83. PubMed ID: 11994390
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions.
Matsumoto K; Date K; Ohmichi H; Nakamura T
Cancer Chemother Pharmacol; 1996; 38 Suppl():S42-7. PubMed ID: 8765416
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of tumor-stromal interaction through HGF/Met signaling by valproic acid.
Matsumoto Y; Motoki T; Kubota S; Takigawa M; Tsubouchi H; Gohda E
Biochem Biophys Res Commun; 2008 Feb; 366(1):110-6. PubMed ID: 18053801
[TBL] [Abstract][Full Text] [Related]
7. Met-Independent Hepatocyte Growth Factor-mediated regulation of cell adhesion in human prostate cancer cells.
Tate A; Isotani S; Bradley MJ; Sikes RA; Davis R; Chung LW; Edlund M
BMC Cancer; 2006 Jul; 6():197. PubMed ID: 16869958
[TBL] [Abstract][Full Text] [Related]
8. The green tea catechins, (-)-Epigallocatechin-3-gallate (EGCG) and (-)-Epicatechin-3-gallate (ECG), inhibit HGF/Met signaling in immortalized and tumorigenic breast epithelial cells.
Bigelow RL; Cardelli JA
Oncogene; 2006 Mar; 25(13):1922-30. PubMed ID: 16449979
[TBL] [Abstract][Full Text] [Related]
9. Chronic exposure to fulvestrant promotes overexpression of the c-Met receptor in breast cancer cells: implications for tumour-stroma interactions.
Hiscox S; Jordan NJ; Jiang W; Harper M; McClelland R; Smith C; Nicholson RI
Endocr Relat Cancer; 2006 Dec; 13(4):1085-99. PubMed ID: 17158755
[TBL] [Abstract][Full Text] [Related]
10. Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy.
Jankowski K; Kucia M; Wysoczynski M; Reca R; Zhao D; Trzyna E; Trent J; Peiper S; Zembala M; Ratajczak J; Houghton P; Janowska-Wieczorek A; Ratajczak MZ
Cancer Res; 2003 Nov; 63(22):7926-35. PubMed ID: 14633723
[TBL] [Abstract][Full Text] [Related]
11. Tumor-stromal cell interaction under hypoxia increases the invasiveness of pancreatic cancer cells through the hepatocyte growth factor/c-Met pathway.
Ide T; Kitajima Y; Miyoshi A; Ohtsuka T; Mitsuno M; Ohtaka K; Koga Y; Miyazaki K
Int J Cancer; 2006 Dec; 119(12):2750-9. PubMed ID: 16998831
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte growth factor/scatter factor (HGF/SF) is produced by human bone marrow stromal cells and promotes proliferation, adhesion and survival of human hematopoietic progenitor cells (CD34+).
Weimar IS; Miranda N; Muller EJ; Hekman A; Kerst JM; de Gast GC; Gerritsen WR
Exp Hematol; 1998 Aug; 26(9):885-94. PubMed ID: 9694510
[TBL] [Abstract][Full Text] [Related]
13. Tumor-stroma interactions reduce the efficacy of adenoviral therapy through the HGF-MET pathway.
Yasui T; Ohuchida K; Zhao M; Onimaru M; Egami T; Fujita H; Ohtsuka T; Mizumoto K; Tanaka M
Cancer Sci; 2011 Feb; 102(2):484-91. PubMed ID: 21105966
[TBL] [Abstract][Full Text] [Related]
14. From Tpr-Met to Met, tumorigenesis and tubes.
Peschard P; Park M
Oncogene; 2007 Feb; 26(9):1276-85. PubMed ID: 17322912
[TBL] [Abstract][Full Text] [Related]
15. Induction of hepatocyte growth factor/scatter factor by fibroblast clustering directly promotes tumor cell invasiveness.
Kankuri E; Cholujova D; Comajova M; Vaheri A; Bizik J
Cancer Res; 2005 Nov; 65(21):9914-22. PubMed ID: 16267016
[TBL] [Abstract][Full Text] [Related]
16. SU5416 is a potent inhibitor of hepatocyte growth factor receptor (c-Met) and blocks HGF-induced invasiveness of human HepG2 hepatoma cells.
Wang SY; Chen B; Zhan YQ; Xu WX; Li CY; Yang RF; Zheng H; Yue PB; Larsen SH; Sun HB; Yang X
J Hepatol; 2004 Aug; 41(2):267-73. PubMed ID: 15288476
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of transforming growth factor-β signaling potentiates tumor cell invasion into collagen matrix induced by fibroblast-derived hepatocyte growth factor.
Oyanagi J; Kojima N; Sato H; Higashi S; Kikuchi K; Sakai K; Matsumoto K; Miyazaki K
Exp Cell Res; 2014 Aug; 326(2):267-79. PubMed ID: 24780821
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of hepatocyte growth factor and c-Met/HGF receptor in benign and malignant human prostate tissue.
Nakashiro K; Hayashi Y; Oyasu R
Oncol Rep; 2003; 10(5):1149-53. PubMed ID: 12883672
[TBL] [Abstract][Full Text] [Related]
19. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma.
Rahimi N; Tremblay E; McAdam L; Park M; Schwall R; Elliott B
Cell Growth Differ; 1996 Feb; 7(2):263-70. PubMed ID: 8822210
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin production in mouse mammary tumour cells confers invasive growth potential by inducing hepatocyte growth factor in stromal fibroblasts.
Matsumoto-Taniura N; Matsumoto K; Nakamura T
Br J Cancer; 1999 Sep; 81(2):194-202. PubMed ID: 10496342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]